About AVIR Dividend Returns
Atea Pharmaceuticals, Inc. (AVIR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of AVIR over the past year?
Atea Pharmaceuticals, Inc. (AVIR) delivered a return of 54.46% over the past year. Since AVIR does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in AVIR be worth today?
A $10,000 investment in Atea Pharmaceuticals, Inc. one year ago would be worth $15,446 today, representing a gain of $5,446.
Q3Does AVIR pay dividends?
Atea Pharmaceuticals, Inc. (AVIR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For AVIR, the total return equals the price-only return.
Q4Did AVIR beat the S&P 500?
Yes, Atea Pharmaceuticals, Inc. (AVIR) outperformed the S&P 500 by 39.00 percentage points over the past year. AVIR delivered a total return of 54.46%, compared to the S&P 500's 15.45%. This 39.00pp alpha means investors in AVIR earned more than a passive S&P 500 index fund.
Q5What is AVIR's worst drawdown?
Atea Pharmaceuticals, Inc. (AVIR) experienced a maximum drawdown of -27.69% over the past year, declining from its peak on 2025-07-25 to its trough on 2025-10-02. The stock recovered to its prior peak by 2026-01-23. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is AVIR's long-term total return over 10, 20, or 30 years?
Atea Pharmaceuticals, Inc. (AVIR) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -84.6% (-17.0% CAGR) — $10,000 would have grown to $1,543. Over 20 years: -84.6% total return (-8.9% CAGR) — $10,000 → $1,543. Over 30 years: -84.6% total return (-6.0% CAGR) — $10,000 → $1,543. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was AVIR's best and worst year?
Atea Pharmaceuticals, Inc.'s best calendar year was 2020 with a total return of 37.7%. Its worst year was 2021 with a total return of -78.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 116.1 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).